BWXT News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

BW

Mkt Cap

$12.57B

Volume

823.05K

Next Earnings

November 2nd

Chart Financials Earnings News About Dividends Insider Filings

BWX Technologies vs. Rocket Lab: Should You Go Nuclear or Go to Space in Your Portfolio?The article compares BWX Technologies and Rocket Lab as investment options, presenting a value versus growth dilemma. BWX offers stability through nuclear infrastructure contracts with the U.S. government and benefits from the nuclear power renaissance, trading at a reasonable 28.6x forward P/E with positive cash flow. Rocket Lab provides high-growth potential with 38% revenue growth but currently burns cash and trades at a premium 191.8x forward P/E, with its $8 billion Iridium acquisition adding complexity. The author recommends BWX Technologies as the better 2026 investment due to its essential role in Navy contracts, reasonable valuation, and predictable profitability.The Motley Fool · Oct 16, 2026

3 Companies Raising Guidance This Earnings SeasonBWX Technologies, Johnson & Johnson, and UnitedHealth Group have all raised their FY26 outlooks following solid quarterly earnings. BWX Technologies saw strong commercial nuclear operations growth, J&J benefited from pharmaceutical portfolio strength, and UnitedHealth Group showed improving cost trends with a lower medical care ratio.Zacks Investment Research · Oct 15, 2026

Is BWXT a Buy as Nuclear Growth Meets Execution and Valuation Risk?BWX Technologies is expanding in defense and commercial nuclear markets with $1.4 billion in naval contracts and raised 2026 guidance to $3.80 billion revenue. However, the stock trades at a 27.10X forward P/E near its five-year median, leaving limited room for execution errors. Margin pressure in commercial operations and concentration of earnings in Q4 present risks, warranting a balanced approach.Zacks Investment Research · Oct 14, 2026

BWXT Falls 19.8% in 3 Months: Does the Pullback Create Opportunity?BWX Technologies shares have declined 19.8% over three months despite 18% revenue growth, a $8.4 billion backlog (up 40% YoY), and raised 2026 guidance. While the pullback improves valuation to 27.10X forward earnings, execution risks remain due to margin pressure, capital intensity in commercial operations, and Q4-heavy earnings concentration.Zacks Investment Research · Oct 14, 2026

BWXT Raises 2026 Guidance as Commercial Nuclear Growth AcceleratesBWX Technologies raised its 2026 revenue outlook to $3.80 billion and adjusted EPS guidance to $4.70-$4.80 following strong Q2 results. Commercial revenues surged 71.7% to $302.5 million, driving full-year growth forecast to 45%. However, the company faces execution risks with 55% of second-half earnings concentrated in Q4 and increased capital spending pressuring Commercial margins.Zacks Investment Research · Oct 14, 2026

Here's Where These 4 Nuclear Reactor Stocks Could Be in 5 YearsThe article analyzes four nuclear reactor stocks and their potential valuations by 2031. Oklo, NuScale Power, and Nano Nuclear Energy face significant execution risks with current stock prices appearing to price in substantial post-2031 growth. BWX Technologies, a more established supplier with existing revenue, carries less commercialization risk but trades at a premium valuation with limited upside room.The Motley Fool · Oct 11, 2026

Can BWX Technologies' Uranium Processing Capabilities Drive Growth?BWX Technologies (BWXT) is expanding its nuclear materials processing capabilities through uranium recovery, purification, and downblending activities. The company's Uranium Processing and Nuclear Services segment revenues grew significantly to $406.6 million in 2025 from $287 million in 2024, with $68.1 million attributed to higher uranium processing and downblending activity. BWXT trades at a discount to industry peers with a forward P/S ratio of 3.23X versus 6.89X industry average, though shares have declined 23.6% over three months. The company holds a Zacks Rank #3 (Hold) with projected EPS growth of 18.45% in 2026 and 10.10% in 2027.Zacks Investment Research · Oct 9, 2026

3 Nuclear Energy Stocks Down 40% or More From Their Highs -- Only 1 Is a Real Opportunity Right Now.Three nuclear energy stocks have fallen significantly from their highs due to market headwinds. NuScale and Oklo, which develop innovative small modular reactors, have plummeted 86% and 79% respectively but lack commercial deployment and trade at extremely high valuations. BWX Technologies, a more established and profitable nuclear supplier with defense contracts, has only pulled back 40% and offers a more balanced opportunity in the resurgent nuclear market.The Motley Fool · Oct 8, 2026

Prediction: This Nuclear Stock Outperforms Oklo and NuScale Through 2030 (Hint: It Already Has Revenue)BWX Technologies is positioned to outperform nuclear peers Oklo and NuScale through 2030 due to its established $3.2 billion revenue base and decades of nuclear manufacturing experience. While Oklo and NuScale are still commercializing reactor technologies, BWXT generates revenue from U.S. Navy contracts, TRISO fuel production, medical isotopes, and is developing advanced reactors and microreactors. The company raised its 2026 revenue guidance to $3.8 billion with 19% growth expected.The Motley Fool · Oct 2, 2026

GE Vernova's BWRX-300 Secures First US Construction PermitGE Vernova received the first U.S. construction permit for its 300-MW BWRX-300 small modular reactor design from the NRC for a Tennessee Valley Authority project in Tennessee. The approval removes a major regulatory hurdle and establishes a foundation for standardized deployment across multiple projects in the U.S. and Canada. The company expects long-term revenue opportunities from fuel, maintenance, and services across the reactor lifecycle.Zacks Investment Research · Oct 2, 2026

BW

BWXTBWX Technologies, Inc.

BWXT

Pay with—

Available Balance0.00

Your PositionYou don't own any BWXT yet.

Related Tickers

Earnings

Dividends

Last · Aug 18Quarterly

Amount$0.27

Yield0.77%

Annual$1.06